Delisting risk
Niki BioSolutions (NIKI)
Develops blood-based brain-health diagnostics and provides molecular biomarker testing services.
$7.00
Pre-market+0.39 (+5.90%)
At close$6.61(−0.15%)
Something off on this page? Send us feedback.
EPSReportedEstimate
—Apr '19Sep '19Sep '20Apr '21Sep '21Sep '22Oct '25
Reported—−$0.53−$31.40−$20.70$39.00−$46.90−$5.30−$0.62
Estimate————————
Surprise————————
RevenueReportedEstimate
—Apr '19Sep '19Sep '20Apr '21Sep '21Sep '22Oct '25
Reported—$383.5K$239.8K$327.3K$584.2K$637.8K$527.5K—
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2025 | — | −$0.62 | — |
| Sep 2022 | — | −$5.30 | — |
| Sep 2021 | — | −$46.90 | — |
| Apr 2021 | — | $39.00 | — |
The latest year is open to everyone — the 3 quarters behind it read with an account. Sign in | |||
| Sep 2020 | |||
| Sep 2019 | |||
| Apr 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | — | −$0.62 | — | — | — | — | −1.7% |
| Sep 30, 2022 | — | −$5.30 | — | — | $527.5K | — | +1.7% |
| Sep 15, 2021 | — | −$46.90 | — | — | $637.8K | — | −4.0% |
| Apr 19, 2021 | — | $39.00 | — | — | $584.2K | — | −6.1% |
The latest year is open to everyone — the 3 quarters behind it read with an account. Sign in | |||||||
| Sep 2, 2020 | |||||||
| Sep 26, 2019 | |||||||
| Apr 15, 2019 | |||||||